Neurology

uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease

~ Achieved statistically significant, dose-dependent, and durable evidence of potential therapeutic benefit; Patients receiving high-dose AMT-130 showed 80% slowing of...

SpringWorks Therapeutics Completes Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN

STAMFORD, Conn., July 01, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe...

RareCyte secures $20M financing to expand the Orion™ Spatial Biology platform including Multiplex Assay Reagents, Software and Precision Biology Services

SEATTLE, June 27, 2024 /PRNewswire/ -- RareCyte, Inc. ("RareCyte" or "the Company") a Life Sciences company providing advanced Precision Biology...

Linus Health Introduces Person-Centered Approach to Establish Clinically Meaningful Benefits and Personalized Brain Health Care

Scalable, systematic and automated process captures and monitors metrics based on patients' treatment priorities for managing Alzheimer's disease and related dementias...

eVisit Acquires UPMC’s Inpatient Teleconsult Technology and Secures Investments from UPMC Enterprises and MedStar Health to Expand Innovative Partnerships and Capabilities

Organizations also join growing list of eVisit co-development and advisory collaborators, strengthening the industry-leading platform recognized as "Best in KLAS" for...

error: Content is protected !!